Innovus Pharmaceuticals Inc (OTCMKTS:INNVD – Get Free Report) shares traded up 143.9% on Monday . The stock traded as high as $3.49 and last traded at $3.00. 4,300 shares changed hands during mid-day ...

The "Over the Counter (OTC) Drugs - Market Insight, Competitive Landscape, Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.The global Over-the-Counter (OTC) drugs market is ...

Aytu operates a consumer health subsidiary, Innovus Pharmaceuticals, Inc. ("Innovus"), a specialty pharmaceutical company commercializing, licensing and developing safe and effective consumer ...

JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a ...

1 Day CPRX 0.09% DJIA 0.27% S&P Mid Cap 400 0.27% Health Care/Life Sciences 0.40% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

1 Day MIRA 10.19% DJIA -0.36% Russell 2K -0.27% Health Care/Life Sciences 0.06% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...

Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...